Skip to main content
. 2023 Aug 18;10(1):e001158. doi: 10.1136/bmjgast-2023-001158

Table 4.

Comparison of symptoms and complications of treatment within case and control groups

Symptom Control group (n=42) P value Case group (n=44) P value
Admission 1 week 2 weeks 3 weeks 4 weeks Admission 1 week 2 weeks 3 weeks 4 weeks
Rectal bleeding 21 19 18 15 12 0.000* 26 19 15 13 8 0.001*
Incomplete defecation 31 27 25 21 21 0.000* 26 24 15 11 12 0.000*
Anal pain 30 28 21 16 15 0.041* 21 21 11 10 6 0.000*
Anal irritation 22 20 13 9 6 0.005* 23 18 10 6 5 0.008*
Anal discharge 13 11 8 7 4 0.000* 13 6 5 4 2 0.220
Anal discomfort 25 24 19 15 13 0.000* 22 17 12 8 7 0.000*
Complication
Diarrhoea 10 6 4 2 2 0.011* 12 4 3 1 0 0.009*
Nausea 9 2 0 0 0 0.024* 10 3 1 1 0 0.029*
Vomiting 5 0 0 0 0 0.560 4 2 1 1 0 0.630
Skin rash 12 5 2 2 1 0.270 9 3 2 0 0 0.067
Pruritus 13 7 2 1 1 0.210 14 5 4 1 0 0.056
Headache 19 3 1 0 0 0.004* 21 11 3 3 0 0.006*
Vertigo 15 4 1 0 0 0.012* 18 7 2 1 0 0.016*

Number of individuals in case and control groups are 44 and 42, respectively (ntotal=86).

*Significant differences between case and control groups.